Search
Now showing items 1-1 of 1
National stakeholder preferences for next-generation rotavirus vaccines: Results from a six-country study
(Elsevier, 2021)
Currently available live, oral rotavirus vaccines (LORVs) have significantly reduced severe rotavirus hospitalizations and deaths worldwide. However, LORVs are not as effective in low- and middle-income countries (LMIC) ...